CD8A and neoplasm: When the expression level of MHC-I—known as human leukocyte antigen (HLA) in humans and histocompatibility system 2 (H-2) in mice—within tumor cells is down-regulated or absent, the cytotoxic effect mediated by CD8+ T cells can be affected, allowing tumor cells to evade immune surveillance and clearance [12, 13].